Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

This study has been terminated.
(Other new drugs)
Information provided by (Responsible Party):
French Innovative Leukemia Organisation Identifier:
First received: June 12, 2009
Last updated: September 15, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)